Electronic nose for detecting abnormal glucose metabolism in heart transplant recipients
Prediabetes or PTDM is common in HTR. eNose technology, especially when combined with clinical data, shows promise as a non-invasive screening tool with high specificity and PPV. This approach may reduce OGTT burden, pending further confirmation.
Authors
- Kadir Çalişkan (ORCID: https://orcid.org/0000-0002-3293-9261)
- Jasper J. Brugts (ORCID: https://orcid.org/0000-0002-5522-9318)
- Marleen M. Goedendorp-Sluimer
- Stefan Roest (ORCID: https://orcid.org/0000-0003-0195-7499)
- Merel E. Hellemons (ORCID: https://orcid.org/0000-0002-6666-5027)
- Olivier C. Manintveld (ORCID: https://orcid.org/0000-0002-2202-7314)
- Daniël Bos (ORCID: https://orcid.org/0000-0001-8979-2603)
- Adrienne A.M. Zandbergen (ORCID: https://orcid.org/0000-0001-5056-5921)
- Nynke Wijbenga (ORCID: https://orcid.org/0000-0003-1681-3324)
- Alina Constantinescu (ORCID: https://orcid.org/0000-0001-7089-0713)
- Babette Dijk (ORCID: https://orcid.org/0009-0007-3156-2232)
- Annelot J. Muntinga (ORCID: https://orcid.org/0009-0004-1311-4450)
Institutions
- Erasmus MC (NL)
- Erasmus MC Cancer Institute (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1186/s12933-025-02970-8
- Primary Topic
- Advanced Chemical Sensor Technologies
- Type
- article
- Field-Weighted Citation Impact
- 0.00